Paper Details

  1. Home
  2. Paper Details

Budesonide for maintenance of remission in Crohn's disease.

Author: BenchimolEric I, GriffithsAnne Marie, KaplanGilaad G, KuenzigM Ellen, OtleyAnthony R, RezaieAli, SeowCynthia H, SteinhartA Hillary

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

While corticosteroids are effective for inducing remission in Crohn's disease, they are not suitable for long-term maintenance due to the risk of adverse events. This review discusses the use of budesonide, a glucocorticoid with limited systemic bioavailability, for inducing remission in Crohn's disease.
Paper Details　
Original Abstract of the Article :
Corticosteroids are effective for induction, but not maintenance of remission in Crohn's disease. Significant concerns exist regarding the risk for adverse events, particularly when corticosteroids are used for long treatment courses. Budesonide is a glucocorticoid with limited systemic bioavailabil...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133546/

データ提供：米国国立医学図書館（NLM）

Budesonide: A New Hope for Crohn's Disease Remission

This study delves into the challenging world of Crohn's disease, a chronic inflammatory bowel disorder. Imagine a desert where the sand constantly shifts and storms rage, creating unpredictable and often painful conditions. Corticosteroids, like a temporary oasis, can effectively induce remission but are not as effective in maintaining it. The study focuses on budesonide, a glucocorticoid with limited systemic bioavailability, and explores its potential for maintaining remission in Crohn's disease. This research is like searching for a more sustainable oasis, one that can provide long-term relief from the harsh conditions of Crohn's disease.

A Potential Oasis for Crohn's Disease Patients

The study's findings suggest that budesonide, with its targeted delivery, could offer a promising approach to maintaining remission in Crohn's disease. It's like discovering a new oasis that can provide a more stable source of water and nourishment. This research opens the door for new treatment options and could bring hope to those struggling with the unpredictable nature of Crohn's disease.

Navigating the Desert of Crohn's Disease

The study highlights the importance of finding effective treatments for Crohn's disease, which can have a profound impact on a person's quality of life. This research offers a glimmer of hope in the vast desert of Crohn's disease, suggesting that budesonide could be a key to achieving and maintaining remission. It's a reminder that research and innovation are essential for finding new solutions to challenging medical conditions.

Dr.Camel's Conclusion

This study explores the potential of budesonide for maintaining remission in Crohn's disease. It's a journey through the desert of inflammatory bowel disorders, searching for a more sustainable oasis of relief. The research offers a hopeful glimpse into the future of Crohn's disease treatment and could lead to more effective and long-lasting therapies.

Date :
  1. Date Completed 2014-09-19
  2. Date Revised 2022-10-07
Further Info :

Pubmed ID

25141071

DOI: Digital Object Identifier

PMC7133546

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.